Roche’s US subsidiary Genentech breaks ground on $700 million manufacturing facility in North Carolina
The $700 million project is part of Roche’s $50 billion investment in US manufacturing, infrastructure and R&D
The $700 million project is part of Roche’s $50 billion investment in US manufacturing, infrastructure and R&D
The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
The new facility will enhance AbbVie’s chemical synthesis capacity to support domestic production of current and next-generation neuroscience, immunology, and oncology medicines
The conference will explore the path to India’s first billion-dollar drug, evolution towards value-based healthcare, biotech breakthroughs, and the role of AI and LLMs in care delivery
Apollo has also announced plans to add over 4,300 beds in the next five years with an investment of over Rs. 7,600 crore
Reinforcing commitment to ethical and sustainable growth
NJ Bio is currently executing a major new program for an existing innovator customer with multiple ADC candidates in their pipeline
NorUDCA is the first?in?class treatment for Non?alcoholic Fatty Liver Disease (NAFLD) in India
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
Subscribe To Our Newsletter & Stay Updated